$3.18
3.05%
Nasdaq, Oct 01, 04:00 pm EDT. Closed.
ISIN
US29970R1059
Symbol
EVAX

Evaxion Biotech A/S - ADR Target price 2026 - Analyst rating & recommendation

Evaxion Biotech A/S - ADR Classifications & Recommendation

Buy
90%
Hold
10%

Evaxion Biotech A/S - ADR Price Target

Target Price $10.20
Price $3.18
Potential
Number of Estimates 6
6 Analysts have issued a price target Evaxion Biotech A/S - ADR 2027 . The average Evaxion Biotech A/S - ADR target price is $10.20. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 9 Analysts recommend Evaxion Biotech A/S - ADR to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Evaxion Biotech A/S - ADR stock has an average upside potential 2027 of . Most analysts recommend the Evaxion Biotech A/S - ADR stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -0.02 -0.57
97.96% 2,750.00%
P/E negative

6 Analysts have issued a Evaxion Biotech A/S - ADR forecast for earnings per share. The average Evaxion Biotech A/S - ADR EPS is

$-0.57
unlock
. This is
2,750.00% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-0.04 100.00%
unlock
, the lowest is
$-1.58 7,800.00%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.02 97.96%
2026
$-0.57 2,750.00%
unlock
2027
$-1.11 94.74%
unlock
2028
$-0.61 45.05%
unlock
2029
$0.08 113.11%
unlock
2030
$-0.01 112.50%
unlock
2031
$0.02 300.00%
unlock
2032
$0.06 200.00%
unlock

P/E ratio

Current -159.00 18.07%
2026
-5.53 96.52%
unlock
2027
-2.86 48.28%
unlock
2028
-5.20 81.82%
unlock
2029
38.97 849.42%
unlock
2030
-311.76 900.00%
unlock
2031
155.88 150.00%
unlock
2032
51.96 66.67%
unlock

Current Evaxion Biotech A/S - ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co.
Locked
➜
Locked
Locked Apr 24 2026
Jones Trading
Locked
➜
Locked
Locked Mar 10 2026
HC Wainwright & Co.
Locked
➜
Locked
Locked Mar 09 2026
Lake Street
Locked
➜
Locked
Locked Mar 09 2026
Edward Jones
Locked
➜
Locked
Locked Oct 30 2025
HC Wainwright & Co.
Locked
➜
Locked
Locked Oct 20 2025
Lake Street
Locked
➜
Locked
Locked Oct 20 2025
Analyst Rating Date
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Apr 24 2026
Locked
Jones Trading:
Locked
➜
Locked
Mar 10 2026
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Mar 09 2026
Locked
Lake Street:
Locked
➜
Locked
Mar 09 2026
Locked
Edward Jones:
Locked
➜
Locked
Oct 30 2025
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Oct 20 2025
Locked
Lake Street:
Locked
➜
Locked
Oct 20 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today